NEJM Gets Letter From DOJ
It’s the fourth journal to confirm receiving a letter asking about alleged bias
Related Articles
‘Eddington’ Review: Joaquin Phoenix and Pedro Pascal Square Off in Ari Aster’s Brazenly Provocative Western Thriller, Set During the Pandemic the Film Says Made America Lose Its Mind
“Eddington,” while not a comedy, presents an angry, sinister, and maybe crazy new America that it views with a deadpan tone of trepidatious glee. And…
Proximity to Golf Courses and Risk of Parkinson Disease
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Conference Coverage
Read our coverage of the major medical conferences that impact thoracic oncologists and surgeons.
Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma
The last 2 decades have seen a paradigm shift in the treatment landscape of metastatic gastric and gastroesophageal adenocarcinomas, with most of the progress occurring…
CAVEAT Trial Hints at New AML Path for Fit Seniors | Blood Cancers Today
Results from the phase 1b study suggest venetoclax plus modified chemotherapy is an effective and well-tolerated approach.
What Does Persistently Active Disease Mean for Patients?
Systemic lupus erythematosus (SLE) is a highly unpredictable disease characterized by significant variability between patients, which makes both prediction and management particularly challenging. In a…
H5N1 Bird Flu Cases Have Slowed in Animals and People
However, CDC researchers recommend continued surveillance
Major Changes in the Treatment of Urothelial Cancer – Tres Uramigas – OncoDaily
Immunotherapy for Urothelial Cancer: Types, Success Rate, Side Effects and More
What Should I Know About Medication Deprescribing?
This JAMA Internal Medicine Patient Page describes the process of slowly and carefully cutting down on unnecessary medications with the guidance of a health care…
Single-Center Study Examines ULT Guideline Adherence | Docwire News
A study examined one medical center’s adherence to gout management guidelines regarding the use of urate-lowering therapy (ULT) to lower uric acid (UA) levels.